Menu
Back to Journals » Breast Cancer: Targets and Therapy » Volume 15
Letter
The Potent Novel CDK4/6 Inhibitor TQB3616 in Hormone Receptor Positive Breast Cancer: Preclinical Characterization with in vitro and Human Tumor Xenograft Models [Letter]
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 1,783 | Dovepress* | 1,731+ | 41 | 1,772 | |
| PubMed Central* | 52 | 26 | 78 | ||
| Totals | 1,783 | 67 | 1,850 | ||
| *Since 19 December 2023 | |||||
View citations on PubMed Central and Google Scholar